Communication Bridge™ for Primary Progressive Aphasia (CB3 Pilot Trial)

N/A

Waitlist Available

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time frame: 5 assessment time points through study completion, an average of 1 year, including change over time

Awards & highlights

No Placebo-Only Group

Summary

This trial will evaluate evidence-based treatments to improve communication and quality of life for adults with PPA and their care-partners. Participants will receive free speech therapy, access to a web application, and more.

Eligible Conditions

Alzheimer's Disease
Acquired Nevi
Dementia
Primary Progressive Aphasia
Aphasia
Communication

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time frame: 5 assessment time points through study completion, an average of 1 year, including change over time

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time frame: 5 assessment time points through study completion, an average of 1 year, including change over time

This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: 5 assessment time points through study completion, an average of 1 year, including change over time for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Communication Confidence (CCRSA)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Experimental: Communication Bridge™Experimental Treatment1 Intervention

Participants receive Communication Bridge™, a multi-component, participation-focused, dyadic intervention in which both the person with PPA and their co-enrolled communication partner are intervention recipients. Communication Bridge™ is modelled on the Living with Aphasia: Framework for Outcome Measurement (A-FROM) and the Care Pathway Model that was developed for persons living with primary progressive aphasia. Consistent with participation-focused intervention models personally salient training stimuli are incorporated into all therapy activities in the Experimental arm.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Communication Bridge™

2018

N/A

~200

Do I qualify?Apply below to find out